An Acellular Anti-Bordetella Bronchiseptica Vaccine Efficiency Test in Wistar Rats by DÉNES, Attila Lehel et al.
 290 
Bulletin UASVM, Veterinary Medicine 66(1)/2009 
ISSN 1843-5270; Electronic ISSN 1843-5378 
 
 
An Acellular Anti-Bordetella Bronchiseptica Vaccine Efficiency Test in 
Wistar Rats 
 
DÉNES Attila Lehel, Ioan MARCUS, Iulia PRODAN, Bogdan SEVASTRE, Nicodim 
FIł, George NADǍŞ, Daniela CǍLINA  
 
University of Agricultural Sciences and Veterinary Medicine, Faculty of Veterinary Medicine 
3-5 Mănăştur Street, 400372, Cluj-Napoca, Romania, e-mail: attila25@email.ro 
 
  
Abstract. The researches were made between February and May 2009 within the 
Microbiology Laboratory of the Faculty of Veterinary Medicine Cluj-Napoca. A number of 6 B. 
bronchiseptica free adolescent female Wistar rats were infected intranazally with a field isolate of B. 
bronchiseptica isolated from a pneumonic pig and the same B. bronchiseptica strain was ultrasound 
disintegrated for the preparation of the acellular vaccine. Three rats were subcutaneously vaccinated in 
days 14 and 28 after infection and in day 60 after infection all rats were euthanized through atlo-
occipital dislocation under ethylic ether anaesthezia. Blood samples, lung and trachea portions were 
collected for bacteriological and serological tests. Clinical observations, serological and 
bacteriological findings showed a good protection given by the vaccine. 
 
Key words: Bordetella bronchiseptica, rats, serology, bacteriology, vaccine, efficiency;  
 
INTRODUCTION 
 
 Bordetella bronchiseptica is a small, Gram-negative cocobacil that colonizes the upper 
respiratory tract of mammals. In healthy rats infection with B. bronchiseptica never leads to 
clinical manifestation but infected rats remains carriers of B. bronchiseptica for all their life 
(3).  
Immunogenic structures of B. bronchiseptica mainly consist of adhesins and toxins. 
The majority of these virulence factors of B. bronchiseptica are expressed only in the virulent 
phase. Adhesins such as filamentous haemagglutinin (FHA), fimbriae (FIM) and pertactin 
(PRN) are expressed on the cell surface and they are highly immunogenic. These structures 
should be contained in a suspension obtained through ultrasound disintegration of B. 
bronchiseptica. Subcutaneous administration of this suspension in rats should lead to a 
protective systemic immune response against these immunogenic structures. 
   
MATERIAL AND METHOD 
 
 The study was performed during February-May 2009 within the Microbiology 
Laboratory of Veterinary Medicine Faculty, Cluj-Napoca. 
Preparation of the acelluler vaccine: a field isolate of B. bronchiseptica isolated from a 
pneumonic pig was used for vaccine preparation. The isolate was grown on five 90 mms 
diameter Petri dishes with 5% blood agar. Insemination of the plates was carried out by 
flooding them with the isolate suspended in distillated water. After 24 hours at 37°C, the cells 
were harvested with 5 ml of 0.85% NaCl per plate, recovering approximately 4 ml B. 
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bronchiseptica suspension from each plate. Suspended B. bronchiseptica cells were 
disintegrated with an ultrasound generator DUS P 150 (INCDFT Iaşi) at 21-22 Khz in 20 ml 
volume. The ultrasound disintegrator worked 90 minutes at a power level of 150 W. After the 
ultrasound treatment, the suspension was distributed in 5 ml volumes in 50/10 mm glass tubes 
and centrifuged at 6000 rpm for 30 minutes. Supernatants were collected and protein content 
of the antigen solutions was measured at the Clinical Laboratory of Veterinary Medicine 
Faculty, Cluj-Napoca. The protein content of the antigen solution was 2.3 mgs/ml. Antigen 
solution was diluted with 0.85% NaCl to a 2.0 mgs/ml protein concentration and 37% 
formalin was added to a final concentration of 0.5%. This antigen solution was kept at 4°C 
and was used for the immunization of the rats and also in the double diffusion test assays. 
Infection of the rats: Six B. bronchiseptica free adolescent female Wistar rats were 
infected with the field isolate of B. bronchiseptica used for vaccine preparation. The rats were 
slightly anaesthetized with halothane. Using a monocanal automatic pipette a droplet of 15 µl 
of the B. bronchiseptica suspension containing 7x107 CFU/ml was introduced in each nostril 
of the rats. Animals were monitored daily for signs of discomfort and respiratory distress.  
Immunization of the rats and sample collection: Three rats were subcutaneously 
vaccinated in days 14 and 28 after infection with 0.2 ml of antigen solution. In day 60 after 
infection all rats were euthanized through atlo-occipital dislocation under ethylic ether 
anesthesia. Blood samples were collected during anesthesia from the retro orbital sinuses, 
lung and trachea portions were collected after euthanasia for bacteriological and serological 
tests. A 0.5 cm section of trachea and an apical pulmonary lobe were removed aseptically, 
triturated in 1 ml of sterile saline solutions. Twofold dilutions were made (1:2, 1:4 and 1:8) 
and 0.25 ml of these solutions were plated on Petri dishes containing MacConkey agar. 
Test of the sera samples:   Sera samples were tested using agar immune diffusion test 
and slow agglutination test. 
Agar for immune diffusion was prepared according to the following formula:   
Medinal: 2.1g, Veronal: 0.37g, NaN3: 0,02g, agar Noble 2.5g and distillated water 200 ml. 
The solution was heated in a water bath at 100°C until the solution became transparent. The 
solution was cooled to 60°C and distributed in Petri dishes of 50 mm in diameter (5 ml for a 
box). After the gel hardened, six peripherical equidistant wells and a central well with 
diameters of 5 mm were performed using a tube of glass provided with a pear.  
To perform these immune diffusion tests, negative control and positive control sera 
were used. They were placed in two peripherical wells facing each other while sera obtained 
from the rats were placed in the remained peripherical wells using a 40 µl volume of sera. 
Antigen solution (the same solution used for vaccination) was placed in every central well (40 
µl each). Petri dishes were incubated at 37°C for 48 hours in a thermostat, where humidity 
was kept high. 
The antigen for the agglutination test was prepared by growing the field isolates of B. 
bronchiseptica on ten plates of 5% blood agar. Insemination of the plates was accomplished 
by flooding the plates with a suspension of the field isolate in distillated water. After 24 hours 
at 37°C, the cells were harvested with phosphate-buffered saline (PBS), pH 7,2. PBS 
contained two solutions: solution I was prepared with 0,907 g  KH2PO4 + 100 ml distillate 
water and solution II was prepared with 1,187g Na2HPO4 dehydrate  and distillated water up 
to 100 ml. 27.4 ml of solution I was mixed with 72.6 ml of solution II to obtain the final PBS 
solution. Prior cell harvesting from each plate rapid haemagglutination test was carried out 
successfully, making sure that  Bordetella bronchiseptica cells are in phase I. Harvested 
organisms were killed with 1% formalin while being held at 4°C for 48 hours with occasional 
shaking. The preparation constituted the stock antigen for the test that was maintained under 
 292 
refrigeration conditions. For preparation of antigen used in the test assay, stock antigen was 
added to PBS to a concentration of 60% transmission (%T) at 625 nm on a Spekol ZV 
Spectrofotometer. 
 Prior to testing, the undiluted sera were inactivated at 56°C for 30 minutes in a water 
bath. The sera were serially diluted in 50 µl volumes with PBS starting with a 1:5 dilution in 
micro titer plates with U type wells, where the first well for each sample contained 250 µl 
PBS and the following wells contained 150 µl PBS. Passing 150 µl diluted sera in the second 
wells, doubling dilution was performed. The antigen (150 µl) was added to every well and the 
plates were incubated in a thermostat for five hours at 55°C than the plates were kept 20 hours 
at 4°C. 
 To determine the agglutination endpoint, tests were read using a desk spot lamp placed 
under the plates at a distance of 30 cm, lighting up the bottom of the wells in a 45 degree 
angle. From above the bottom of the wells were examined with a magnifying glass and with a 
digital Canon camera set on Supermacro function. The agglutinin pattern was judged as 
positive when only definite granules of antigen were seen in a layer covering the bottom of 
the wells. The highest dilution of serum giving a positive reaction was taken as the titer (1, 2). 
Bacteriological tests: After euthanasia the nasal cavities of the rats were washed with 
10 µl of PBS to determine the presence or the absence of B. bronchiseptica at this anatomical 
site. PBS was recovered by aspiration and samples were inseminated on Petri dishes 
containing MacConkey agar. A 0.5 cm section of trachea and an apical pulmonary lobe were 
removed aseptically from every animal and triturated in 1 ml of sterile saline solutions. 
Twofold dilutions were made (1:2, 1:4 and 1:8) and 0.25 ml of these solutions were plated on 
Petri dishes containing MacConkey agar and incubated aerobically at 37°C for 48 hours. After 
incubation colonies of B. bronchiseptica were counted on every plate to determine the number 
of CFU for each trachea portion and each apical pulmonary lobe. 
 
RESULTS AND DISCUTIONS 
 
The immune diffusion test in unvaccinated rats did not revealed any immune response 
to B. bronchiseptica infection, while in vaccinated rats this test was positive for every animal. 
In the vaccinated group the immune diffusion assay showed a single precipitation line with 
antigenic community among these lines and the line obtained between the antigen and the 
positive control serum. It is obvious that these differences observed in the immune diffusion 
assays between vaccinated group and unvaccinated group are given by antibodies produced 
due to vaccine administration. 
Regarding the slow agglutination test two of the unvaccinated rats hat an antibody titer 
of 1:5 and one of them had a higher titer (1:20). Vaccinated rats had higher antibody titers 
then the unvaccinated group, two of them had a titer of 1:40 and one rat had a titer of 1:80. 
Bacteriological findings showed that all unvaccinated rats were B. bronchiseptica 
carriers, the bacteria was isolated in all cases both from the nasal cavities and the trachea, but 
not from the lung samples. In the vaccinated group only one rat was found to be B. 
bronchiseptica carrier. In this case the bacterium was isolated from the trachea of one of the 
rats with an antibody titer of 1:40. 
Serological findings showed a clear systemic immune response after vaccine 
administration and bacteriological findings showed that immune response due to vaccine 
administration was a protective one. 
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CONCLUSIONS 
 
• Double immune diffusion test and slow agglutination test showed a significant rise of 
antibody levels produced against B. bronchiseptica in infected and vaccinated rats 
group  compared with the infected but unvaccinated rats group;  
• Bacteriological findings showed that immune response due to vaccine administration 
was a protective one;  
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